Interferon Alpha-2b Therapy in Chronic Hepatitis Delta

BACKGROUND: Approximately 5% of hepatitis B virus (HBV) carriers are coinfected with hepatitis D virus (HDV). HBV/HDV coinfection is a major cause of cirrhosis and end stage liver disease in chronic HBsAg carriers. The only approved therapy for chronic hepatitis delta is interferon alpha (IFN α) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Keshvari, Maryam, Alavian, Seyed Moayed, Sharafi, Heidar, Karimi, Gharib, Gholami Fesharaki, Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989544/
https://www.ncbi.nlm.nih.gov/pubmed/24744790
http://dx.doi.org/10.5812/hepatmon.15729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989544/
https://www.ncbi.nlm.nih.gov/pubmed/24744790
http://dx.doi.org/10.5812/hepatmon.15729

Ejemplares similares